Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000041083 | SCV000051695 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041083 | SCV000064774 | benign | not specified | 2012-02-23 | criteria provided, single submitter | clinical testing | Pro3752Leu in exon 45B of TTN: This variant is not expected to have clinical sig nificance because it is not located within the splice consensus sequence and has been identified in 1.1% (73/6658) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS; dbSNP rs33971253). Pro3752Leu in exon 45B of TTN (rs33971253; allele frequ ency = 1.1%, 73/6658) ** |
Gene |
RCV000041083 | SCV000169572 | benign | not specified | 2013-08-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001083374 | SCV000262072 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000041083 | SCV000307151 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000619761 | SCV000735089 | benign | Cardiovascular phenotype | 2015-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769091 | SCV000900464 | benign | Cardiomyopathy | 2015-12-03 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852923 | SCV000995667 | benign | Hypertrophic cardiomyopathy; Supraventricular tachycardia | 2019-03-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000206781 | SCV001146315 | benign | not provided | 2019-07-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000206781 | SCV001159544 | benign | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839785 | SCV002100867 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839786 | SCV002100868 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839787 | SCV002100869 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839784 | SCV002100870 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000206781 | SCV002544178 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000206781 | SCV005241351 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000206781 | SCV001741456 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000206781 | SCV001800404 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041083 | SCV001917425 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041083 | SCV001929109 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041083 | SCV001957584 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041083 | SCV001969843 | benign | not specified | no assertion criteria provided | clinical testing |